Background: autoimmune diseases (ADS) are associated with sepsis. This
study aims to investigate the causalities between ADs and sepsis using
Mendelian randomization (MR). Methods: we extracted single-nucleotide
polymorphisms (SNPs) closely associated with 10 ADs, including systemic
lupus erythematosus (SLE), rheumatoid arthritis (RA), type 1 diabetes
(T1D), multiple sclerosis (MS), inflammatory bowel disease (IBD), celiac
disease (CD), psoriasis (PsO), primary sclerosing cholangitis (PSC),
primary biliary cholangitis (PBC), and ulcerative colitis (UC) from the
GWAS. Two-sample MR analysis was conducted using GWAS data from the UK
Biobank to assess the association between the liability of each ad and
sepsis and sepsis-related 28-day mortality. The inverse
variance-weighted (IVW) method was used as the primary analysis. If
sig-nificant causal relationships are found (considering multiple
comparisons) in the univariate MR analysis, multivariate MR (MVMR)
analysis is performed to adjust for body mass index (BMI) and smoking. A
series of sensitivity analyses were conducted to validate the robustness
of the results. Results: after adjusting for multiple testing, MR
analysis revealed that PSC patients are responsible for increased
susceptibility to sepsis using the IVW method (OR:1.033,
95%CI:1.007-1.060, PFDR = 0.020). Further sensitivity analyses
validated the robustness of the above association. Even after adjusting
for BMI and smoking, the MVMR-IVW still displayed a positive
correlation(OR:1.043, 95%CI:1.022-1.064, P-value for IVW = 3.32E-05)
between PSC patients and susceptibility to sepsis. However, no
significant causal relationship was observed between SLE, RA, T1D, MS,
IBD, CD, PsO, PBC, and UC with susceptibility to sepsis or short-term
death risk. Conclusions: our MR analysis revealed a genetic
susceptibility of PSC to sepsis. However, no causal relationship was
observed between SLE, RA, T1D, MS, IBD, CD, PsO, PBC, and UC with
suscep-tibility to sepsis or short-term death risk. Keywords: autoimmune
diseases; sepsis; primary sclerosing cholangitis; Mendelian
randomization